Regulatory Writer I
About the role
Position Title: Regulatory Writer I
Department: Regulatory
About Ora
At Ora, we are building the future of ophthalmic clinical research. As the world’s leading full-service ophthalmic drug and device development firm, we guide our clients across all phases of clinical research to efficiently bring new products and therapies to market. Over the past 45 years, our expert teams have helped earn more than 85 new product approvals. Ora's pre-clinical and clinical models, unique methodologies, integrated clinical data solutions, and global regulatory strategies have been refined and proven across thousands of global projects.
The Role
Our Regulatory Writer I is responsible for researching, writing, and editing materials for regulatory submission to the FDA from pre-clinical to clinical trials Phase 1 - 4. This is an individual contributor working on a team as an active partner in regulatory project planning and execution reporting to the Manager of Regulatory. Ora’s Regulatory Writer I will work collaboratively with our Clinical Project Managers, Clinical Trial Associates (CTA) and cross-functional departments such as Clinical Operations, Quality Assurance, Operations and Chemical Manufacturing Control (CMC). The Regulatory Writer I will identify and execute the timeline plans for clinical, nonclinical, and CMC by way of coordinating, authoring, and developing domestic and international drug applications and submissions in support of clinical programs within the US and globally.
What You’ll Do
- Author and compile FDA and Ex-US regulatory applications and submissions, inclusive of general correspondence, INDs, CTAs, protocol and information amendments, annual reports, Safety reports, meeting briefing documents, PSPs, and NDAs/MAAs, as well as peer-reviewed manuscripts, slide decks, and posters with oversight and assistance as needed.
- Assist in the research of scientific and regulatory information in order to write submission documents.
- Work with data management and clinical teams, as well as sponsors and KOLs to review protocol development and interpret clinical trial data for CSRs.